Perceptions and Representations of Vaccination Against COVID-19

SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high:

According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19.

To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHI Villeneuve-Saint-Georges

Villeneuve-Saint-Georges, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Over 18 years of age
Patient with a scheduled appointment in consultation or at the vaccination centre
Not opposed to participation in the protocol

Exclusion criteria

Patient under guardianship or curatorship
Patient unable to give free and informed consent
Patient under court protection
Patient without the cognitive capacity to ensure an interview

Treatment and study plan

Interview

Behavioral

Face to face semi-directed interviews about perceptions, representations and experiences of Covid-19 vaccination, including six opened-questions

Primary outcomes

Perceptions, representations and experiences of Covid-19 vaccination

Time frame: 1 hour

Interview based on 6 opened questions

Secondary outcomes

Key elements to improve the medical discourse on vaccination

Time frame: 1 hour

Interview based on 6 opened questions

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Intercommunal Creteil

Other

Collaborators

Centre Hospitalier Intercommunal Villeneuve Saint Georges

Registry information

Acronym: PERCECOVAC

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: May 21, 2021
Registry last updated: Dec 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed